CS Extension
Notes
**Note 1**: If there is a discrepancy between the Clark level and the pathologic description of extent (invasion into the layers of the dermis), use the higher (more extensive) code. **Note 2**: Code the greatest extent of invasion from any procedure performed on the lesion, whether it is described as a biopsy or an excision. For example, if a punch biopsy with involvement of Clark level IV is followed by a re-excision with residual tumor involving Clark level II, use code 300 (Clark level IV). **Note 3**: Satellite lesions/nodules or in-transit metastases are coded in CS Lymph Nodes. **Note 4**: Ulceration of the melanoma is coded in CS Site-Specific Factor 2.| Code | Description | AJCC 7 T | AJCC 6 T | Summary Stage 1977 T | Summary Stage 2000 T |
|---|---|---|---|---|---|
| 000 | In situ, intraepidermal, intraepithelial, noninvasive (Basement membrane of the epidermis is intact) Clark level I |
Tis | Tis | IS | IS |
| 100 | Papillary dermis invaded Clark level II |
Thickness Ulceration AJCC7 | Thickness Ulceration AJCC6 | L | L |
| 200 | Papillary-reticular dermal interface invaded Clark level III |
Thickness Ulceration AJCC7 | Thickness Ulceration AJCC6 | L | L |
| 300 | Reticular dermis invaded Clark level IV |
Thickness Ulceration AJCC7 | Thickness Ulceration AJCC6 | L | L |
| 310 | Stated as T1a with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 315 | Stated as T1b with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 320 | Stated as T1 [NOS] with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 330 | Stated as T2a with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 335 | Stated as T2b with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 340 | Stated as T2 [NOS] with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 350 | Stated as T3a with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 355 | Stated as T3b with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 360 | Stated as T3 [NOS] with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 370 | Stated as T4a with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 375 | Stated as T4b with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 380 | Stated as T4 [NOS] with no other information on extension | Extension Thickness Ulceration T Category AJCC7 | Extension Thickness Ulceration T Category AJCC6 | L | L |
| 400 | Skin/dermis, NOS Localized, NOS |
Thickness Ulceration AJCC7 | Thickness Ulceration AJCC6 | L | L |
| 500 | Subcutaneous tissue invaded (through entire dermis) Clark's level V |
Thickness Ulceration AJCC7 | Thickness Ulceration AJCC6 | L | RE |
| 800 | Further contiguous extension: Underlying cartilage, bone, skeletal muscle |
Thickness Ulceration AJCC7 | Thickness Ulceration AJCC6 | D | D |
| 950 | No evidence of primary tumor | T0 | T0 | U | U |
| 999 | Unknown; extension not stated Primary tumor cannot be assessed Not documented in patient record |
Thickness Ulceration AJCC7 | Thickness Ulceration AJCC6 | U | U |